Drug Trial Radar · NCT01623310
12-Month OL Intranasal Fluticasone Propionate BID Using OptiNose Device
Last checked: Nov 19, 2026Latest source record: Jan 24, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
223
Actual
Start
Sep 2013
Primary completion
Aug 2015
Study completion Oct 2015
Sponsor
- Lead sponsor
- Optinose US Inc.Industry
- Sponsor type
- Industry
- First posted
- Jun 19, 2012
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an open-label, multicenter study designed to assess the safety of intranasal administration of 400 μg of fluticasone propionate twice a day delivered by the OptiNose device in subjects with chronic sinusitis with or without nasal polyps. The study consists of an up-to-7-day pretreatment phase followed a 12-month open-label treatment phase. The duration of each subject's participation is approximately 53 weeks.
Conditions
- Nasal Polyps
Interventions
Fluticasone PropionateDrug
Using Optinose Exhalation Delivery System
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adverse EventsTime frame: 12 Months
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Achieve Clinical Research
Birmingham, Alabama
PAB Clinical Research
Brandon, Florida
Sneeze Wheeze and Itch Associates
Normal, Illinois
Professional Research Network of Kansas
Wichita, Kansas
Best Clinical Trials
New Orleans, Louisiana
PMG Research of Winston Salem
Winston-Salem, North Carolina
HCCA Clinical Research Solutions
Middleburg Heights, Ohio
Allergy and Asthma Research Group
Eugene, Oregon
Clinical Research Solutions
Franklin, Tennessee
William Blake Partners
Grapevine, Texas
Focus Clinical Research
Draper, Utah
InterMountain Ear Nose and Throat
Salt Lake City, Utah
Advanced Clinical Research
West Jordan, Utah
Premier Clinical Research
Spokane, Washington
Exemplar Research
Fairmont, West Virginia
Allergy Asthma and Sinus Center
Greenfield, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.